Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cancer Discovery
|
June 11, 2013
A new alpha in line between KRAS and NF-κB activation?
Chorom Pak, Shigeki Miyamoto
SLAS Discovery : Advancing Life Sciences R & D
|
February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest Group
Chorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
Blood
|
January 21, 2012
Microscale functional cytomics for studying hematologic cancers
Edmond W K Young, Chorom Pak, Brad S Kahl, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 23, 2015
MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells
Chorom Pak, Natalie S Callander, Edmond W K Young, et al.
The Journal of Biological Chemistry
|
December 28, 2017
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
Mailee Huynh, Chorom Pak, Stephanie Markovina, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cancer Discovery
|
June 11, 2013
A new alpha in line between KRAS and NF-κB activation?
Chorom Pak, Shigeki Miyamoto
SLAS Discovery : Advancing Life Sciences R & D
|
February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest Group
Chorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
Blood
|
January 21, 2012
Microscale functional cytomics for studying hematologic cancers
Edmond W K Young, Chorom Pak, Brad S Kahl, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 23, 2015
MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells
Chorom Pak, Natalie S Callander, Edmond W K Young, et al.
The Journal of Biological Chemistry
|
December 28, 2017
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
Mailee Huynh, Chorom Pak, Stephanie Markovina, et al.
Page
of 1